Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma

Albert Jang, Jake N. Lichterman, Jeffrey Y. Zhong, Jonathan E. Shoag, Jorge A. Garcia, Tian Zhang, Pedro C. Barata

Open source

DOI
10.1080/21645515.2023.2276629
Published
2023-11-10
Container
Human Vaccines & Immunotherapeutics
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21645515.2023.2276629,
  title = {Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma},
  author = {Albert Jang and Jake N. Lichterman and Jeffrey Y. Zhong and Jonathan E. Shoag and Jorge A. Garcia and Tian Zhang and Pedro C. Barata},
  year = {2023},
  journal = {Human Vaccines \& Immunotherapeutics},
  doi = {10.1080/21645515.2023.2276629},
  url = {https://doi.org/10.1080/21645515.2023.2276629}
}

RIS

TY  - JOUR
TI  - Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma
AU  - Albert Jang
AU  - Jake N. Lichterman
AU  - Jeffrey Y. Zhong
AU  - Jonathan E. Shoag
AU  - Jorge A. Garcia
AU  - Tian Zhang
AU  - Pedro C. Barata
PY  - 2023
JO  - Human Vaccines & Immunotherapeutics
DO  - 10.1080/21645515.2023.2276629
UR  - https://doi.org/10.1080/21645515.2023.2276629
ER  - 

APA

Jang, A., Lichterman, J. N., Zhong, J. Y., Shoag, J. E., Garcia, J. A., Zhang, T., & Barata, P. C. (2023). Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2023.2276629

Source records